NCT01996501View on ClinicalTrials.gov

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fed Condition

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

January 31, 2009

Conditions
Healthy
Interventions
DRUG

Olanzapine Orally Disintegrating 5mg Tablets

Trial Locations (1)

382428

Bio Evaluation Centre, Torrent Pharmaceuticals Ltd., Village Bhat, Gandhinagar

All Listed Sponsors
lead

Torrent Pharmaceuticals Limited

INDUSTRY

NCT01996501 - Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fed Condition | Biotech Hunter | Biotech Hunter